Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Parkinson's disease AND ("QT" OR Torsad*):

Domperidone for Hypotension in Parkinson's Disease: A Systematic Review. Bacchi S et al. J Parkinsons Dis. (2017)

Autonomic and electrocardiographic findings in Parkinson's disease. Gibbons CH et al. Auton Neurosci. (2017)

Clinical features and electrocardiogram parameters in Parkinson's disease. Mochizuki H et al. Neurol Int. (2017)

Search results

Items: 1 to 20 of 103

1.

[Circadian changes in the structure of cardiac rhythm during pre-symptomatic and symptomatic stages of Parkinson's disease].

Mamalyga ML, Mamalyga LM.

Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(8):85-90. doi: 10.17116/jnevro201811808185. Russian.

PMID:
30251984
2.

Familial clustering of cardiac conditions in patients with anomalous aortic origin of a coronary artery and myocardial bridges.

Agrawal H, Mery CM, Sexson Tejtel SK, Fraser CD, McKenzie ED, Qureshi AM, Molossi S.

Cardiol Young. 2018 Sep;28(9):1099-1105. doi: 10.1017/S1047951118000835. Epub 2018 Jul 13.

PMID:
30001755
3.

Clinical features and electrocardiogram parameters in Parkinson's disease.

Mochizuki H, Ishii N, Shiomi K, Nakazato M.

Neurol Int. 2017 Dec 11;9(4):7356. doi: 10.4081/ni.2017.7356. eCollection 2017 Dec 11.

4.

Efficacy and safety of amantadine for the treatment of L-DOPA-induced dyskinesia.

Perez-Lloret S, Rascol O.

J Neural Transm (Vienna). 2018 Aug;125(8):1237-1250. doi: 10.1007/s00702-018-1869-1. Epub 2018 Mar 7. Review.

PMID:
29511826
5.

Pimavanserin: A novel therapeutic option for Parkinson disease psychosis.

Hawkins T, Berman BD.

Neurol Clin Pract. 2017 Apr;7(2):157-162. doi: 10.1212/CPJ.0000000000000342. Review.

6.

Optimal Screening Methods to Detect Cardiac Disorders in Athletes: An Evidence-Based Review.

Winkelmann ZK, Crossway AK.

J Athl Train. 2017 Dec;52(12):1168-1170. doi: 10.4085/1062-6050-52.11.24. Epub 2017 Nov 20. Review.

7.

Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy.

Müller-Rebstein S, Trenkwalder C, Ebentheuer J, Oertel WH, Culmsee C, Höglinger GU.

CNS Drugs. 2017 Dec;31(12):1093-1102. doi: 10.1007/s40263-017-0478-0.

PMID:
29139041
8.

Domperidone for Hypotension in Parkinson's Disease: A Systematic Review.

Bacchi S, Chim I, Kramer P, Postuma RB.

J Parkinsons Dis. 2017;7(4):603-617. doi: 10.3233/JPD-171209. Review.

PMID:
29103053
9.

Structural and functional alterations of the heart in Parkinson's disease.

Piqueras-Flores J, López-García A, Moreno-Reig Á, González-Martínez A, Hernández-González A, Vaamonde-Gamo J, Jurado-Román A.

Neurol Res. 2018 Jan;40(1):53-61. doi: 10.1080/01616412.2017.1390933. Epub 2017 Oct 23.

PMID:
29057715
10.

Artefact mimicking torsades: treat the patient not the ECG.

Bergin U, Lynch RM.

Practitioner. 2017 Feb;261(1801):23-6.

PMID:
29020721
11.

Targeted temperature management after out-of-hospital cardiac arrest in three young patients.

Godinjak A, Iglica A, Kukuljac A, Tančica I, Jusufović S, Ajanović A, Rožajac Š.

Acta Med Acad. 2017 May;46(1):50-54. doi: 10.5644/ama2006-124.186.

12.

Epicardial cardioverter-defibrillator implantation in a 4-month-old infant bridged to heart transplantation.

Carro C, Cereda AF, Annoni G, Marianeschi SM.

Interact Cardiovasc Thorac Surg. 2017 Nov 1;25(5):832-833. doi: 10.1093/icvts/ivx129.

PMID:
28510647
13.

Autonomic and electrocardiographic findings in Parkinson's disease.

Gibbons CH, Simon DK, Huang M, Tilley B, Aminoff MJ, Bainbridge JL, Brodsky M, Freeman R, Goudreau J, Hamill RW, Luo ST, Singer C, Videnovic A, Bodis-Wollner I, Wong PS; NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators.

Auton Neurosci. 2017 Jul;205:93-98. doi: 10.1016/j.autneu.2017.04.002. Epub 2017 Apr 14.

14.

Novel Variant in the ANK2 Membrane-Binding Domain Is Associated With Ankyrin-B Syndrome and Structural Heart Disease in a First Nations Population With a High Rate of Long QT Syndrome.

Swayne LA, Murphy NP, Asuri S, Chen L, Xu X, McIntosh S, Wang C, Lancione PJ, Roberts JD, Kerr C, Sanatani S, Sherwin E, Kline CF, Zhang M, Mohler PJ, Arbour LT.

Circ Cardiovasc Genet. 2017 Jan;10(1). pii: e001537. doi: 10.1161/CIRCGENETICS.116.001537.

15.

Are Olympic athletes free from cardiovascular diseases? Systematic investigation in 2352 participants from Athens 2004 to Sochi 2014.

Pelliccia A, Adami PE, Quattrini F, Squeo MR, Caselli S, Verdile L, Maestrini V, Di Paolo F, Pisicchio C, Ciardo R, Spataro A.

Br J Sports Med. 2017 Feb;51(4):238-243. doi: 10.1136/bjsports-2016-096961. Epub 2016 Dec 30.

PMID:
28039126
16.

Demographics and Epidemiology of Sudden Deaths in Young Competitive Athletes: From the United States National Registry.

Maron BJ, Haas TS, Ahluwalia A, Murphy CJ, Garberich RF.

Am J Med. 2016 Nov;129(11):1170-1177. doi: 10.1016/j.amjmed.2016.02.031. Epub 2016 Apr 1.

PMID:
27039955
17.

AVN-101: A Multi-Target Drug Candidate for the Treatment of CNS Disorders.

Ivachtchenko AV, Lavrovsky Y, Okun I.

J Alzheimers Dis. 2016 May 25;53(2):583-620. doi: 10.3233/JAD-151146. Review.

18.

Evaluation of opicapone on cardiac repolarization in a thorough QT/QTc study.

Pinto R, l'Hostis P, Patat A, Homery MC, Falcão A, Nunes T, Rocha JF, Soares-da-Silva P.

Clin Pharmacol Drug Dev. 2015 Nov;4(6):454-62. doi: 10.1002/cpdd.188. Epub 2015 May 7.

PMID:
27137718
19.

Drugs with potential cardiac adverse effects: Retrospective study in a large cohort of parkinsonian patients.

Heranval A, Lefaucheur R, Fetter D, Rouillé A, Le Goff F, Maltête D.

Rev Neurol (Paris). 2016 Apr-May;172(4-5):318-23. doi: 10.1016/j.neurol.2015.11.007. Epub 2016 Apr 7.

PMID:
27063094
20.

The 12-lead electrocardiogram and risk of sudden death: current utility and future prospects.

Narayanan K, Chugh SS.

Europace. 2015 Oct;17 Suppl 2:ii7-13. doi: 10.1093/europace/euv121. Review.

Supplemental Content

Loading ...
Support Center